SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-058151
Filing Date
2010-11-12
Accepted
2010-11-12 16:44:59
Documents
5
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-17669_110q.htm 10-Q 566781
2 EX-31.1 a10-17669_1ex31d1.htm EX-31.1 12685
3 EX-31.2 a10-17669_1ex31d2.htm EX-31.2 12513
4 EX-32.1 a10-17669_1ex32d1.htm EX-32.1 5767
5 EX-32.2 a10-17669_1ex32d2.htm EX-32.2 5825
  Complete submission text file 0001104659-10-058151.txt   605101
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 101187352
SIC: 2836 Biological Products, (No Diagnostic Substances)